Biotechnology
The Biotechnology industry has a total of 589 stocks, with a combined market cap of $1.34 trillion and total revenue of $115.79 billion.
Market Cap
1.34T
Revenue
115.79B
Profits
-38.76B
PE Ratio
n/a
Profit Margin
-33.48%
Dividend Yield
0.04%
589 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 133.83B | -3.32% | 637,290 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.98B | -2.02% | 319,884 | 15.53B |
| 3 | ARGX | argenx SE | 62.97B | -2.19% | 175,543 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 55.94B | -3.72% | 8,385,345 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 44.25B | -1.70% | 1,296,535 | - |
| 6 | ONC | BeOne Medicines AG | 39.98B | -1.86% | 282,918 | 6.13B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 34.88B | -2.05% | 1,470,340 | 4.80B |
| 8 | RPRX | Royalty Pharma plc | 34.77B | -5.46% | 6,964,221 | 2.54B |
| 9 | ROIV | Roivant Sciences Ltd. | 30.07B | 19.18% | 20,890,814 | 7.53M |
| 10 | INSM | Insmed Incorporated | 27.27B | -1.13% | 1,085,514 | 1.14B |
| 11 | INCY | Incyte Corporation | 25.43B | -1.00% | 639,605 | 5.82B |
| 12 | BNTX | BioNTech SE | 24.86B | -4.62% | 912,825 | 3.03B |
| 13 | GMAB | Genmab A/S | 20.11B | -0.09% | 1,314,388 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 17.74B | -0.16% | 336,093 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.58B | -2.76% | 297,701 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.59B | -0.31% | 1,646,266 | 713.07M |
| 17 | EXEL | Exelixis, Inc. | 14.40B | -1.54% | 1,311,567 | 2.44B |
| 18 | SMMT | Summit Therapeutics Inc. | 13.94B | -0.71% | 5,336,588 | - |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.51B | -2.89% | 914,883 | 3.41B |
| 20 | CORT | Corcept Therapeutics Incorporated | 12.34B | 2.30% | 596,579 | 830.81M |
| 21 | HALO | Halozyme Therapeutics, Inc. | 12.32B | -1.45% | 990,657 | 1.66B |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.30B | -1.57% | 128,599 | 1.28B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.03B | -1.38% | 916,128 | 669.50M |
| 24 | TECH | Bio-Techne Corporation | 11.34B | -0.15% | 1,620,235 | 1.22B |
| 25 | AXSM | Axsome Therapeutics, Inc. | 10.89B | 0.60% | 225,401 | 776.57M |
| 26 | CYTK | Cytokinetics, Incorporated | 10.44B | 3.30% | 1,444,510 | 67.67M |
| 27 | KRYS | Krystal Biotech, Inc. | 10.43B | -1.68% | 152,322 | 440.48M |
| 28 | ABVX | ABIVAX Société Anonyme | 9.93B | 4.29% | 1,427,663 | 5.67M |
| 29 | PRAX | Praxis Precision Medicines, Inc. | 9.85B | 0.28% | 194,561 | 7.46M |
| 30 | KYMR | Kymera Therapeutics, Inc. | 9.71B | -0.56% | 459,988 | 105.00M |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 9.42B | -0.15% | 305,258 | 281.99M |
| 32 | IONS | Ionis Pharmaceuticals, Inc. | 9.34B | -3.20% | 7,821,551 | 874.09M |
| 33 | PCVX | Vaxcyte, Inc. | 8.98B | -1.31% | 708,756 | - |
| 34 | IBRX | ImmunityBio, Inc. | 8.66B | 1.18% | 6,084,781 | 165.79M |
| 35 | IMVT | Immunovant, Inc. | 8.13B | 0.23% | 955,382 | - |
| 36 | SYRE | Spyre Therapeutics, Inc. | 7.97B | 1.53% | 991,623 | - |
| 37 | TGTX | TG Therapeutics, Inc. | 7.89B | -0.67% | 773,936 | 799.54M |
| 38 | BLTE | Belite Bio, Inc | 7.71B | -1.10% | 491,734 | - |
| 39 | CAI | Caris Life Sciences, Inc. | 7.04B | -0.64% | 3,861,967 | 989.61M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.02B | -0.73% | 315,537 | 239.92M |
| 41 | SRRK | Scholar Rock Holding Corporation | 6.95B | 3.07% | 743,167 | - |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 6.48B | -1.10% | 454,783 | 618.07M |
| 43 | CGON | CG Oncology, Inc. | 6.45B | -2.48% | 374,203 | 6.23M |
| 44 | ORKA | Oruka Therapeutics, Inc. | 6.26B | 2.12% | 664,677 | - |
| 45 | TVTX | Travere Therapeutics, Inc. | 6.22B | 1.07% | 1,015,149 | 591.33M |
| 46 | DNTH | Dianthus Therapeutics, Inc. | 6.12B | 1.23% | 415,260 | 1.90M |
| 47 | COGT | Cogent Biosciences, Inc. | 6.11B | 1.35% | 1,606,748 | - |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.76B | -0.37% | 456,653 | 7.50M |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.76B | -0.43% | 623,580 | 1.01B |
| 50 | LGND | Ligand Pharmaceuticals Incorporated | 5.74B | 0.86% | 178,570 | 290.54M |
| 51 | ERAS | Erasca, Inc. | 5.68B | 0.31% | 3,239,960 | - |
| 52 | CRSP | CRISPR Therapeutics AG | 5.29B | -1.86% | 1,163,137 | 13.39M |
| 53 | DFTX | Definium Therapeutics, Inc. | 5.12B | 0.13% | 1,128,923 | - |
| 54 | PBLS | Parabilis Medicines, Inc. | 4.93B | -1.26% | 458,795 | 148.00K |
| 55 | ACAD | ACADIA Pharmaceuticals Inc. | 4.80B | -0.68% | 931,290 | 1.14B |
| 56 | EWTX | Edgewise Therapeutics, Inc. | 4.75B | 1.58% | 815,078 | - |
| 57 | CELC | Celcuity Inc. | 4.56B | -2.73% | 729,641 | - |
| 58 | ELVN | Enliven Therapeutics, Inc. | 4.35B | 0.03% | 538,576 | - |
| 59 | MANE | Veradermics, Incorporated | 4.29B | 4.28% | 483,187 | - |
| 60 | RLAY | Relay Therapeutics, Inc. | 4.16B | -0.29% | 2,746,783 | 10.35M |
| 61 | TLX | Telix Pharmaceuticals Limited | 4.05B | 1.17% | 271,000 | 890.79M |
| 62 | LEGN | Legend Biotech Corporation | 3.98B | -4.60% | 1,241,245 | 1.27B |
| 63 | IOVA | Iovance Biotherapeutics, Inc. | 3.94B | -1.14% | 7,101,533 | 324.97M |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.93B | -3.44% | 1,433,959 | - |
| 65 | DYN | Dyne Therapeutics, Inc. | 3.84B | -15.36% | 15,393,892 | - |
| 66 | TARS | Tarsus Pharmaceuticals, Inc. | 3.83B | -3.88% | 1,382,738 | 606.33M |
| 67 | TNGX | Tango Therapeutics, Inc. | 3.83B | 0.82% | 1,654,325 | 53.81M |
| 68 | IDYA | IDEAYA Biosciences, Inc. | 3.75B | -2.46% | 593,032 | 234.13M |
| 69 | ABCL | AbCellera Biologics Inc. | 3.72B | 0.44% | 2,167,077 | 66.17M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.71B | -1.79% | 1,043,927 | 117.00M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.53B | -0.83% | 1,131,464 | 3.60M |
| 72 | QURE | uniQure N.V. | 3.18B | 2.96% | 984,460 | 18.67M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 3.12B | 3.81% | 3,455,078 | 463.98M |
| 74 | CLDX | Celldex Therapeutics, Inc. | 3.08B | -1.16% | 676,755 | 158.00K |
| 75 | NAMS | NewAmsterdam Pharma Company N.V. | 3.04B | 0.24% | 3,277,892 | 7.12M |
| 76 | IMNM | Immunome, Inc. | 3.04B | 0.04% | 569,907 | 4.02M |
| 77 | MBX | MBX Biosciences, Inc. | 3.04B | 2.11% | 184,246 | - |
| 78 | IRON | Disc Medicine, Inc. | 2.97B | -2.44% | 291,871 | - |
| 79 | GPCR | Structure Therapeutics Inc. | 2.89B | -14.45% | 2,832,092 | - |
| 80 | ZLAB | Zai Lab Limited | 2.85B | -3.05% | 610,909 | 449.61M |
| 81 | SLS | SELLAS Life Sciences Group, Inc. | 2.81B | 0.22% | 5,322,601 | - |
| 82 | MLYS | Mineralys Therapeutics, Inc. | 2.74B | 9.89% | 2,130,555 | - |
| 83 | NRIX | Nurix Therapeutics, Inc. | 2.70B | -0.38% | 989,328 | 36.77M |
| 84 | ATAI | AtaiBeckley Inc. | 2.69B | -1.76% | 31,375,112 | 4.47M |
| 85 | BEAM | Beam Therapeutics Inc. | 2.69B | -9.34% | 5,494,943 | 156.04M |
| 86 | PHVS | Pharvaris N.V. | 2.68B | 8.17% | 5,710,281 | - |
| 87 | VRDN | Viridian Therapeutics, Inc. | 2.65B | 2.23% | 1,348,727 | 71.13M |
| 88 | NKTR | Nektar Therapeutics | 2.59B | 2.10% | 684,667 | 54.59M |
| 89 | VERA | Vera Therapeutics, Inc. | 2.54B | -1.95% | 685,542 | - |
| 90 | OCUL | Ocular Therapeutix, Inc. | 2.51B | 7.24% | 1,948,021 | 52.06M |
| 91 | HRMY | Harmony Biosciences Holdings, Inc. | 2.48B | 0.62% | 1,347,030 | 959.90M |
| 92 | PGEN | Precigen, Inc. | 2.46B | -3.38% | 2,123,472 | 85.72M |
| 93 | TRVI | Trevi Therapeutics, Inc. | 2.39B | -2.90% | 1,064,903 | - |
| 94 | NUVB | Nuvation Bio Inc. | 2.34B | -1.98% | 1,553,678 | 169.90M |
| 95 | BHVN | Biohaven Ltd. | 2.25B | -4.97% | 2,597,975 | - |
| 96 | RAPP | Rapport Therapeutics, Inc. | 2.23B | 1.51% | 375,262 | 20.00M |
| 97 | PVLA | Palvella Therapeutics, Inc. | 2.22B | -1.87% | 128,766 | - |
| 98 | SRPT | Sarepta Therapeutics, Inc. | 2.21B | -6.93% | 5,057,991 | 1.97B |
| 99 | KOD | Kodiak Sciences Inc. | 2.17B | -1.98% | 453,109 | - |
| 100 | ZBIO | Zenas BioPharma, Inc. | 2.15B | 0.40% | 311,713 | 1.00M |
| 101 | MESO | Mesoblast Limited | 2.15B | -4.85% | 132,656 | 120.25M |
| 102 | AUPH | Aurinia Pharmaceuticals Inc. | 2.15B | 0.37% | 635,940 | 311.51M |
| 103 | URGN | UroGen Pharma Ltd. | 2.14B | -0.79% | 287,361 | 188.73M |
| 104 | ADMA | ADMA Biologics, Inc. | 2.14B | -0.78% | 1,293,327 | 512.28M |
| 105 | KLRA | Kailera Therapeutics, Inc. | 2.13B | 1.11% | 820,215 | - |
| 106 | COAG | Hemab Therapeutics Holdings, Inc. | 2.07B | -0.25% | 264,684 | - |
| 107 | KARD | Kardigan, Inc. | 2.04B | 4.80% | 452,045 | - |
| 108 | GENB | Generate Biomedicines, Inc. | 2.04B | -3.11% | 1,055,146 | 26.48M |
| 109 | AGIO | Agios Pharmaceuticals, Inc. | 2.01B | 1.81% | 494,160 | 98.34M |
| 110 | VCEL | Vericel Corporation | 2.01B | -2.26% | 274,963 | 306.30M |
| 111 | ZYME | Zymeworks Inc. | 2.00B | -3.46% | 272,948 | 37.13M |
| 112 | NBTX | Nanobiotix S.A. | 1.96B | -2.19% | 97,462 | 38.27M |
| 113 | STOK | Stoke Therapeutics, Inc. | 1.95B | 1.14% | 454,314 | 27.59M |
| 114 | GHRS | GH Research PLC | 1.90B | -1.74% | 174,725 | - |
| 115 | VIR | Vir Biotechnology, Inc. | 1.89B | -1.80% | 1,029,308 | 303.23M |
| 116 | XNCR | Xencor, Inc. | 1.88B | -5.04% | 851,248 | 104.97M |
| 117 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.87B | -1.78% | 1,662,107 | 208.78M |
| 118 | BRVE | Braveheart Bio, Inc. | 1.86B | 8.60% | 568,607 | - |
| 119 | RXRX | Recursion Pharmaceuticals, Inc. | 1.86B | -4.55% | 12,724,758 | 54.86M |
| 120 | IMCR | Immunocore Holdings plc | 1.82B | -2.02% | 404,204 | 430.78M |
| 121 | LKFT | Lakefront Biotherapeutics NV | 1.82B | -3.02% | 119,862 | 1.13B |
| 122 | DMRA | Damora Therapeutics, Inc. | 1.81B | -2.50% | 452,872 | - |
| 123 | TSHA | Taysha Gene Therapies, Inc. | 1.80B | -1.61% | 1,058,646 | 5.49M |
| 124 | NTLA | Intellia Therapeutics, Inc. | 1.79B | 0.08% | 3,475,080 | 59.51M |
| 125 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | -2.92% | 845,327 | 252.25M |
| 126 | SEPN | Septerna, Inc. | 1.75B | 2.23% | 197,522 | 98.88M |
| 127 | AVLN | Avalyn Pharma Inc. | 1.70B | 2.41% | 186,140 | - |
| 128 | NVAX | Novavax, Inc. | 1.68B | -0.59% | 3,427,392 | 413.80M |
| 129 | ANAB | AnaptysBio, Inc. | 1.66B | -1.00% | 774,600 | 232.39M |
| 130 | INBX | Inhibrx Biosciences, Inc. | 1.66B | -6.84% | 1,512,817 | 1.30M |
| 131 | FTRE | Fortrea Holdings Inc. | 1.63B | -3.22% | 1,209,733 | 2.68B |
| 132 | APMD | Apnimed, Inc. | 1.62B | 6.67% | 319,312 | 120.15M |
| 133 | AAPG | Ascentage Pharma Group International | 1.60B | -1.45% | 20,002 | 94.61M |
| 134 | TYRA | Tyra Biosciences, Inc. | 1.60B | -6.25% | 968,835 | - |
| 135 | LTGO | Latigo Biotherapeutics, Inc. | 1.59B | 4.34% | 264,801 | - |
| 136 | LBRX | LB Pharmaceuticals Inc | 1.58B | -0.54% | 232,461 | - |
| 137 | BCAX | Bicara Therapeutics Inc. | 1.58B | 3.06% | 395,749 | - |
| 138 | INVA | Innoviva, Inc. | 1.55B | 0.28% | 472,785 | 440.00M |
| 139 | ABSI | Absci Corporation | 1.53B | 1.36% | 1,916,811 | 1.56M |
| 140 | AVBP | ArriVent BioPharma, Inc. | 1.51B | -0.95% | 577,909 | - |
| 141 | TRAX | First Tracks Biotherapeutics, Inc. | 1.50B | 3.83% | 362,908 | - |
| 142 | VOR | Vor Biopharma Inc. | 1.50B | 1.00% | 661,728 | - |
| 143 | SLBT | SL Science Holding Limited | 1.48B | -9.72% | 101,447 | 3.27M |
| 144 | MAZE | Maze Therapeutics, Inc. | 1.47B | 1.18% | 222,737 | 20.00M |
| 145 | RARE | Ultragenyx Pharmaceutical Inc. | 1.46B | -2.88% | 4,044,500 | 717.00M |
| 146 | SVRA | Savara Inc. | 1.41B | 3.35% | 1,177,151 | - |
| 147 | ANRO | Alto Neuroscience, Inc. | 1.40B | 0.31% | 320,561 | - |
| 148 | CGEM | Cullinan Therapeutics, Inc. | 1.39B | -2.08% | 717,322 | - |
| 149 | AKTS | Aktis Oncology, Inc. | 1.39B | -7.65% | 446,487 | 10.06M |
| 150 | REPL | Replimune Group, Inc. | 1.39B | -2.06% | 752,647 | - |
| 151 | OMER | Omeros Corporation | 1.38B | 0.84% | 714,473 | 38.42M |
| 152 | ALMS | Alumis Inc. | 1.38B | -4.23% | 3,521,715 | 7.40M |
| 153 | DRTS | Alpha Tau Medical Ltd. | 1.37B | -1.13% | 490,492 | - |
| 154 | MNKD | MannKind Corporation | 1.34B | 2.71% | 3,892,960 | 393.63M |
| 155 | ODTX | Odyssey Therapeutics, Inc. | 1.32B | -4.31% | 127,533 | 99.00K |
| 156 | ORIC | ORIC Pharmaceuticals, Inc. | 1.31B | -1.71% | 649,528 | - |
| 157 | SPTX | Seaport Therapeutics, Inc. | 1.30B | -2.11% | 117,609 | - |
| 158 | MGTX | MeiraGTx Holdings plc | 1.30B | -2.59% | 402,939 | 397.50M |
| 159 | IMTX | Immatics N.V. | 1.29B | -1.46% | 533,297 | 47.65M |
| 160 | MLTX | MoonLake Immunotherapeutics | 1.27B | -0.47% | 1,189,306 | - |
| 161 | JBIO | Jade Biosciences, Inc. | 1.25B | -1.06% | 545,087 | - |
| 162 | JANX | Janux Therapeutics, Inc. | 1.22B | -1.28% | 568,505 | 24.00M |
| 163 | GLUE | Monte Rosa Therapeutics, Inc. | 1.21B | 2.60% | 838,612 | 28.73M |
| 164 | CRVS | Corvus Pharmaceuticals, Inc. | 1.17B | -3.34% | 756,543 | - |
| 165 | OBX | Obsidian Therapeutics, Inc. | 1.17B | 12.54% | 555,385 | - |
| 166 | ATTO | Attovia Therapeutics, Inc. | 1.12B | -3.87% | 220,956 | 1.80M |
| 167 | KURA | Kura Oncology, Inc. | 1.12B | -5.28% | 1,225,526 | 77.23M |
| 168 | IVA | Inventiva S.A. | 1.11B | -2.41% | 1,206,349 | 7.94M |
| 169 | AVTX | Avalo Therapeutics, Inc. | 1.07B | 3.28% | 641,575 | 59.00K |
| 170 | SLDB | Solid Biosciences Inc. | 1.06B | -3.80% | 497,059 | - |
| 171 | ANL | Adlai Nortye Group Ltd. | 1.03B | 6.60% | 332,320 | 18.06M |
| 172 | SANA | Sana Biotechnology, Inc. | 1.03B | -10.91% | 4,005,278 | - |
| 173 | ABUS | Arbutus Biopharma Corporation | 1.02B | 0.58% | 2,801,724 | 181.72M |
| 174 | FTH | Faeth Therapeutics, Inc. | 1.01B | -2.77% | 254,003 | - |
| 175 | LXRX | Lexicon Pharmaceuticals, Inc. | 987.80M | -0.89% | 1,209,063 | 41.47M |
| 176 | GERN | Geron Corporation | 973.35M | -3.50% | 6,320,184 | 204.56M |
| 177 | SGP | SpyGlass Pharma, Inc. | 965.81M | -0.22% | 97,625 | - |
| 178 | CADL | Candel Therapeutics, Inc. | 965.66M | -1.25% | 856,770 | - |
| 179 | WVE | Wave Life Sciences, Inc. | 965.54M | 0.82% | 2,467,179 | 65.37M |
| 180 | DSGN | Design Therapeutics, Inc. | 959.06M | 1.22% | 616,405 | - |
| 181 | OLMA | Olema Pharmaceuticals, Inc. | 958.97M | 1.95% | 519,534 | - |
| 182 | IMMX | Immix Biopharma, Inc. | 940.74M | -5.46% | 1,107,199 | - |
| 183 | ARDX | Ardelyx, Inc. | 939.44M | -0.26% | 2,180,762 | 450.89M |
| 184 | CLYM | Climb Bio, Inc. | 916.68M | 2.84% | 706,215 | - |
| 185 | HELP | Cybin Inc. | 906.68M | 1.55% | 1,462,524 | - |
| 186 | RIGL | Rigel Pharmaceuticals, Inc. | 888.04M | -2.32% | 185,666 | 276.79M |
| 187 | TBPH | Theravance Biopharma, Inc. | 886.51M | -0.03% | 126,161 | 104.31M |
| 188 | CBIO | Crescent Biopharma, Inc. | 885.98M | -0.86% | 578,442 | 11.88M |
| 189 | ACRS | Aclaris Therapeutics, Inc. | 884.67M | -2.59% | 2,125,984 | 8.22M |
| 190 | ANNX | Annexon, Inc. | 883.44M | -4.31% | 1,682,648 | - |
| 191 | SLN | Silence Therapeutics plc | 827.28M | -5.83% | 1,185,950 | 615.00K |
| 192 | FDMT | 4D Molecular Therapeutics, Inc. | 813.75M | -1.60% | 416,223 | 92.01M |
| 193 | PHAR | Pharming Group N.V. | 808.19M | 2.05% | 16,819 | 366.48M |
| 194 | ACHV | Achieve Life Sciences, Inc. | 807.78M | -7.54% | 2,426,258 | - |
| 195 | DBVT | DBV Technologies S.A. | 801.91M | -1.11% | 158,125 | 5.04M |
| 196 | CTMX | CytomX Therapeutics, Inc. | 789.88M | -2.29% | 1,527,120 | 18.30M |
| 197 | NVCT | Nuvectis Pharma, Inc. | 784.23M | -1.72% | 92,584 | - |
| 198 | MPLT | MapLight Therapeutics, Inc. | 775.28M | 1.31% | 362,391 | - |
| 199 | MNPR | Monopar Therapeutics Inc. | 773.24M | -2.01% | 75,781 | - |
| 200 | NGNE | Neurogene Inc. | 762.23M | -1.32% | 169,722 | 925.00K |
| 201 | GYRE | Gyre Therapeutics, Inc. | 761.32M | 4.66% | 214,241 | 109.82M |
| 202 | AURA | Aura Biosciences, Inc. | 758.08M | -3.31% | 348,668 | - |
| 203 | ZVRA | Zevra Therapeutics, Inc. | 752.99M | 2.26% | 913,430 | 136.07M |
| 204 | PHAT | Phathom Pharmaceuticals, Inc. | 751.41M | -0.42% | 768,014 | 239.66M |
| 205 | OCS | Oculis Holding AG | 751.28M | - | 96,018 | 1.45M |
| 206 | VSTM | Verastem, Inc. | 734.47M | -1.10% | 2,786,558 | 87.53M |
| 207 | ASMB | Assembly Biosciences, Inc. | 718.93M | -3.52% | 168,242 | 74.85M |
| 208 | AGMB | AgomAb Therapeutics NV | 718.04M | -7.60% | 240,850 | - |
| 209 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 710.34M | -1.34% | 103,296 | - |
| 210 | BLSM | BlossomHill Therapeutics, Inc. | 690.10M | 2.32% | 191,690 | - |
| 211 | MDXG | MiMedx Group, Inc. | 686.53M | 3.06% | 773,304 | 355.17M |
| 212 | SGMT | Sagimet Biosciences Inc. | 662.61M | -2.56% | 641,056 | - |
| 213 | STTK | Shattuck Labs, Inc. | 657.38M | -3.53% | 744,317 | 1.00M |
| 214 | DRUG | Bright Minds Biosciences Inc. | 656.57M | 1.67% | 43,963 | - |
| 215 | VALN | Valneva SE | 655.76M | 1.74% | 23,925 | 163.30M |
| 216 | ALT | Altimmune, Inc. | 654.55M | -1.61% | 2,994,750 | 31.00K |
| 217 | ALLO | Allogene Therapeutics, Inc. | 640.89M | -5.84% | 6,663,254 | 4.64M |
| 218 | CRMD | CorMedix Inc. | 638.36M | -2.85% | 851,243 | 462.25M |
| 219 | PRME | Prime Medicine, Inc. | 629.78M | -4.32% | 2,996,234 | 4.07M |
| 220 | PROK | ProKidney Corp. | 607.67M | - | 764,322 | 818.00K |
| 221 | CTNM | Contineum Therapeutics, Inc. | 604.95M | -3.71% | 218,554 | - |
| 222 | OABI | OmniAb, Inc. | 603.37M | -4.16% | 895,081 | 38.46M |
| 223 | TECX | Tectonic Therapeutic, Inc. | 598.41M | -0.46% | 71,002 | - |
| 224 | ARVN | Arvinas, Inc. | 591.09M | -3.73% | 373,662 | 316.70M |
| 225 | SCTX | Scribe Therapeutics Inc. | 589.91M | 8.69% | 185,390 | 33.30M |
| 226 | ZURA | Zura Bio Limited | 589.35M | -1.28% | 1,198,075 | - |
| 227 | EIKN | Eikon Therapeutics, Inc. | 583.36M | -0.83% | 392,896 | - |
| 228 | RGNX | REGENXBIO Inc. | 579.60M | -1.79% | 676,514 | 174.48M |
| 229 | AUTL | Autolus Therapeutics plc | 562.93M | -5.58% | 2,354,834 | 117.39M |
| 230 | CABA | Cabaletta Bio, Inc. | 561.20M | -4.61% | 2,489,768 | - |
| 231 | EPRX | Eupraxia Pharmaceuticals Inc. | 554.49M | -0.95% | 303,332 | - |
| 232 | PRLD | Prelude Therapeutics Incorporated | 542.78M | -3.48% | 151,466 | 22.42M |
| 233 | SPRY | ARS Pharmaceuticals, Inc. | 541.99M | -3.02% | 777,425 | 116.93M |
| 234 | OVID | Ovid Therapeutics Inc. | 539.02M | -1.43% | 768,299 | 1.58M |
| 235 | ARTV | Artiva Biotherapeutics, Inc. | 529.97M | -3.13% | 162,581 | 251.00K |
| 236 | CAPR | Capricor Therapeutics, Inc. | 526.45M | -3.67% | 2,126,970 | 11.13M |
| 237 | ENTX | Entera Bio Ltd. | 519.43M | - | 771,140 | 42.00K |
| 238 | KYTX | Kyverna Therapeutics, Inc. | 500.93M | -1.82% | 482,645 | - |
| 239 | PRTA | Prothena Corporation plc | 491.81M | -2.44% | 182,450 | 54.53M |
| 240 | PBYI | Puma Biotechnology, Inc. | 485.23M | -1.57% | 270,239 | 231.24M |
| 241 | EVMN | Evommune, Inc. | 477.60M | 7.25% | 962,633 | 10.00M |
| 242 | DNA | Ginkgo Bioworks Holdings, Inc. | 467.34M | -0.14% | 883,491 | 132.42M |
| 243 | EDIT | Editas Medicine, Inc. | 466.88M | -5.88% | 1,741,731 | 47.01M |
| 244 | RZLT | Rezolute, Inc. | 458.61M | -4.15% | 512,969 | - |
| 245 | AVIR | Atea Pharmaceuticals, Inc. | 452.76M | -3.17% | 135,943 | - |
| 246 | OCGN | Ocugen, Inc. | 452.71M | -1.84% | 2,294,156 | 4.58M |
| 247 | IKT | Inhibikase Therapeutics, Inc. | 451.36M | -0.84% | 240,930 | 1.00 |
| 248 | VOGX | Vogenx, Inc. | 450.76M | 2.07% | 138,983 | - |
| 249 | RLMD | Relmada Therapeutics, Inc. | 450.68M | -4.63% | 1,284,503 | - |
| 250 | ARCT | Arcturus Therapeutics Holdings Inc. | 445.67M | -0.88% | 467,324 | 29.37M |
| 251 | CCCC | C4 Therapeutics, Inc. | 439.20M | -5.05% | 1,859,529 | 35.04M |
| 252 | FENC | Fennec Pharmaceuticals Inc. | 437.29M | 0.65% | 195,375 | 59.22M |
| 253 | BNTC | Benitec Biopharma Inc. | 434.58M | -0.24% | 82,269 | - |
| 254 | LRMR | Larimar Therapeutics, Inc. | 418.58M | 4.70% | 766,224 | - |
| 255 | GALT | Galectin Therapeutics Inc. | 415.50M | -10.63% | 339,188 | - |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 407.26M | -3.89% | 586,499 | - |
| 257 | VTVT | vTv Therapeutics Inc. | 406.79M | -1.83% | 22,428 | 36.84M |
| 258 | CMPX | Compass Therapeutics, Inc. | 399.80M | -6.72% | 1,899,648 | 850.00K |
| 259 | ENTA | Enanta Pharmaceuticals, Inc. | 394.36M | -3.84% | 109,836 | 65.26M |
| 260 | LXEO | Lexeo Therapeutics, Inc. | 392.98M | -2.04% | 226,643 | - |
| 261 | EYPT | EyePoint, Inc. | 389.68M | -1.31% | 1,546,148 | 2.79M |
| 262 | PALI | Palisade Bio, Inc. | 381.65M | 4.78% | 3,292,091 | 500.00K |
| 263 | ZNTL | Zentalis Pharmaceuticals, Inc. | 381.53M | 1.00% | 385,028 | 26.87M |
| 264 | IPSC | Century Therapeutics, Inc. | 376.64M | -1.42% | 179,016 | 109.16M |
| 265 | TTRX | Turn Therapeutics Inc. | 365.50M | 25.20% | 299,220 | - |
| 266 | IRD | Opus Genetics, Inc. | 364.40M | -6.21% | 2,045,799 | 9.86M |
| 267 | DMAC | DiaMedica Therapeutics Inc. | 354.83M | -2.52% | 89,815 | - |
| 268 | QTTB | Q32 Bio Inc. | 349.49M | -2.09% | 468,635 | 53.74M |
| 269 | AGEN | Agenus Inc. | 338.78M | -8.68% | 974,358 | 132.69M |
| 270 | XFOR | X4 Pharmaceuticals, Inc. | 337.59M | -15.72% | 2,101,852 | 15.85M |
| 271 | SION | Sionna Therapeutics, Inc. | 336.38M | 3.62% | 615,678 | - |
| 272 | ABEO | Abeona Therapeutics Inc. | 336.24M | -2.00% | 558,421 | 25.52M |
| 273 | VCRE | Vicore Pharma Holding AB (publ) | 335.45M | 1.64% | 5,343 | 412.09K |
| 274 | UPB | Upstream Bio, Inc. | 334.65M | 1.66% | 685,077 | 3.16M |
| 275 | SABS | SAB Biotherapeutics, Inc. | 332.10M | -1.88% | 124,461 | 114.70K |
| 276 | LYEL | Lyell Immunopharma, Inc. | 329.84M | -6.33% | 64,789 | 27.00K |
| 277 | PYXS | Pyxis Oncology, Inc. | 324.46M | - | 892,743 | 11.04M |
| 278 | VNDA | Vanda Pharmaceuticals Inc. | 323.48M | -1.47% | 424,037 | 215.72M |
| 279 | IFRX | InflaRx N.V. | 321.26M | -1.80% | 375,874 | -11.54K |
| 280 | OBIO | Orchestra BioMed Holdings, Inc. | 321.26M | 5.22% | 282,856 | 31.98M |
| 281 | STRO | Sutro Biopharma, Inc. | 317.20M | -4.68% | 108,536 | 45.70M |
| 282 | IMRX | Immuneering Corporation | 308.61M | -1.04% | 884,737 | - |
| 283 | FATE | Fate Therapeutics, Inc. | 301.35M | 1.41% | 1,785,255 | 6.49M |
| 284 | BCYC | Bicycle Therapeutics plc | 295.37M | -1.86% | 216,427 | 61.21M |
| 285 | CUVL | Clinuvel Pharmaceuticals Limited | 293.89M | -6.90% | 49,827 | 65.05M |
| 286 | YDES | YD Bio Limited | 291.83M | 17.23% | 499,359 | 510.36K |
| 287 | FULC | Fulcrum Therapeutics, Inc. | 291.46M | -0.78% | 803,683 | 80.00M |
| 288 | PRQR | ProQR Therapeutics N.V. | 287.89M | -1.45% | 401,756 | 21.05M |
| 289 | FHTX | Foghorn Therapeutics Inc. | 286.24M | -2.03% | 167,895 | 36.74M |
| 290 | LCTX | Lineage Cell Therapeutics, Inc. | 280.73M | 2.78% | 1,170,996 | 13.08M |
| 291 | ALEC | Alector, Inc. | 277.47M | 1.02% | 760,985 | 13.86M |
| 292 | ALXO | ALX Oncology Holdings Inc. | 277.25M | -0.25% | 354,152 | - |
| 293 | ACIU | AC Immune SA | 276.41M | -2.80% | 82,279 | 21.67M |
| 294 | TRDA | Entrada Therapeutics, Inc. | 275.84M | 7.29% | 356,461 | 4.69M |
| 295 | MGNX | MacroGenics, Inc. | 275.18M | -1.82% | 324,600 | 175.14M |
| 296 | CAMP | Camp4 Therapeutics Corporation | 274.23M | -0.91% | 252,566 | 4.22M |
| 297 | RNAC | Cartesian Therapeutics, Inc. | 274.11M | -2.27% | 47,303 | 1.48M |
| 298 | AVXL | Anavex Life Sciences Corp. | 264.65M | -0.17% | 410,897 | - |
| 299 | SRZN | Surrozen, Inc. | 251.53M | -5.98% | 174,412 | 11.51M |
| 300 | WHWK | Whitehawk Therapeutics, Inc. | 250.27M | -4.57% | 126,719 | 7.15M |
| 301 | NAGE | Niagen Bioscience, Inc. | 247.39M | -1.58% | 423,688 | 129.08M |
| 302 | CLLS | Cellectis S.A. | 245.99M | - | 33,431 | 63.82M |
| 303 | CGEN | Compugen Ltd. | 245.34M | - | 176,811 | 74.00M |
| 304 | INDP | Indaptus Therapeutics, Inc. | 243.83M | 50.00% | 7,805,958 | - |
| 305 | IVVD | Invivyd, Inc. | 240.38M | -1.27% | 1,840,206 | 58.37M |
| 306 | ELDN | Eledon Pharmaceuticals, Inc. | 237.52M | -3.31% | 714,429 | - |
| 307 | NMRA | Neumora Therapeutics, Inc. | 235.81M | -4.20% | 609,395 | - |
| 308 | NGEN | NervGen Pharma Corp. | 233.86M | -6.65% | 680,085 | - |
| 309 | ADAG | Adagene Inc. | 233.66M | -2.79% | 178,826 | 9.29M |
| 310 | GLSI | Greenwich LifeSciences, Inc. | 232.36M | -0.75% | 44,976 | - |
| 311 | NKTX | Nkarta, Inc. | 229.92M | 9.93% | 1,045,387 | - |
| 312 | TARA | Protara Therapeutics, Inc. | 229.88M | -1.27% | 311,143 | - |
| 313 | ABOS | Acumen Pharmaceuticals, Inc. | 229.25M | -0.31% | 304,368 | - |
| 314 | TNXP | Tonix Pharmaceuticals Holding Corp. | 226.74M | 0.61% | 328,751 | 29.10M |
| 315 | ANTX | AN2 Therapeutics, Inc. | 226.42M | 1.87% | 295,206 | - |
| 316 | SLGL | Sol-Gel Technologies Ltd. | 226.27M | -0.59% | 34,309 | 1.80M |
| 317 | VRXA | Veraxa Biotech AG | 225.55M | -9.38% | 440,274 | 29.54K |
| 318 | PEPG | PepGen Inc. | 222.67M | 3.38% | 1,805,339 | - |
| 319 | KROS | Keros Therapeutics, Inc. | 220.87M | -1.59% | 47,022 | 15.01M |
| 320 | CUE | Cue Biopharma, Inc. | 216.66M | 8.69% | 242,106 | 37.66M |
| 321 | ARMP | Armata Pharmaceuticals, Inc. | 216.03M | -0.51% | 41,549 | 5.54M |
| 322 | PLX | Protalix BioTherapeutics, Inc. | 213.92M | -0.56% | 774,579 | 80.62M |
| 323 | VYGR | Voyager Therapeutics, Inc. | 211.97M | -1.99% | 296,940 | 34.46M |
| 324 | CHRS | Coherus Oncology, Inc. | 211.67M | -3.52% | 438,568 | 50.94M |
| 325 | ACOG | Alpha Cognition Inc. | 211.24M | 1.89% | 64,018 | 15.26M |
| 326 | NBP | NovaBridge Biosciences | 208.80M | - | 119,462 | - |
| 327 | NERV | Minerva Neurosciences, Inc. | 206.75M | -2.26% | 61,114 | - |
| 328 | ORMP | Oramed Pharmaceuticals Inc. | 205.49M | -1.40% | 91,943 | 2.00M |
| 329 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 205.21M | -4.24% | 816,115 | - |
| 330 | DTIL | Precision BioSciences, Inc. | 204.53M | -0.80% | 109,560 | 45.06M |
| 331 | KRRO | Korro Bio, Inc. | 198.94M | 10.38% | 94,559 | 2.38M |
| 332 | MSLE | Satellos Bioscience Inc. | 190.92M | 3.18% | 80,127 | - |
| 333 | RNA | Atrium Therapeutics, Inc. | 190.73M | -21.42% | 1,501,463 | 35.84M |
| 334 | IPHA | Innate Pharma S.A. | 186.80M | -1.92% | 26,298 | 10.57M |
| 335 | CNTN | Canton Strategic Holdings, Inc. | 179.28M | -1.32% | 482,490 | 1.50M |
| 336 | IMUX | Immunic, Inc. | 175.06M | -2.14% | 333,009 | - |
| 337 | MDWD | MediWound Ltd. | 173.26M | 0.98% | 155,995 | 11.86M |
| 338 | SPRB | Spruce Biosciences, Inc. | 170.30M | 2.29% | 156,300 | 697.00K |
| 339 | LENZ | LENZ Therapeutics, Inc. | 168.41M | -10.07% | 496,843 | 21.48M |
| 340 | CRBU | Caribou Biosciences, Inc. | 166.71M | -0.96% | 553,427 | 10.04M |
| 341 | HUMA | Humacyte, Inc. | 165.68M | -1.41% | 2,179,043 | 2.12M |
| 342 | KZIA | Kazia Therapeutics Limited | 165.13M | -2.11% | 137,210 | 1.27M |
| 343 | MOLN | Molecular Partners AG | 161.96M | - | 154 | 856.30K |
| 344 | MENS | Jyong Biotech Ltd. | 161.09M | -9.21% | 34,539 | - |
| 345 | MIST | Milestone Pharmaceuticals Inc. | 159.93M | -5.42% | 1,568,174 | 2.34M |
| 346 | CDXS | Codexis, Inc. | 157.69M | -1.37% | 533,462 | 77.68M |
| 347 | OTLK | Outlook Therapeutics, Inc. | 156.03M | -3.84% | 4,644,187 | -1.16M |
| 348 | EQ | Equillium, Inc. | 155.67M | 11.09% | 578,686 | 4.39M |
| 349 | NRXP | NRx Pharmaceuticals, Inc. | 149.26M | -1.15% | 636,440 | 3.39M |
| 350 | TNYA | Tenaya Therapeutics, Inc. | 148.69M | -2.94% | 2,146,537 | 1.34M |
| 351 | INO | Inovio Pharmaceuticals, Inc. | 145.79M | -1.40% | 3,267,233 | 65.34K |
| 352 | BMEA | Biomea Fusion, Inc. | 142.07M | -3.45% | 1,750,509 | - |
| 353 | UNCY | Unicycive Therapeutics, Inc. | 140.95M | -1.94% | 680,792 | - |
| 354 | OKUR | OnKure Therapeutics, Inc. | 138.50M | -4.47% | 75,628 | - |
| 355 | HURA | TuHURA Biosciences, Inc. | 135.74M | -0.47% | 302,768 | - |
| 356 | ENGN | enGene Therapeutics Inc. | 128.62M | 5.49% | 1,331,053 | - |
| 357 | TLSA | Tiziana Life Sciences Ltd | 128.01M | -2.94% | 835,145 | - |
| 358 | CNXU | Conexeu Sciences Inc. | 125.76M | -5.43% | 255,543 | - |
| 359 | CBUS | Cibus, Inc. | 124.20M | 2.20% | 57,043 | 4.35M |
| 360 | VANI | Vivani Medical, Inc. | 124.03M | -7.72% | 424,324 | - |
| 361 | RANI | Rani Therapeutics Holdings, Inc. | 121.97M | 1.12% | 503,015 | 4.88M |
| 362 | BDTX | Black Diamond Therapeutics, Inc. | 120.37M | -1.18% | 300,244 | 70.00M |
| 363 | CNTB | Connect Biopharma Holdings Limited | 120.28M | 3.80% | 1,084,254 | 2.95M |
| 364 | NAUT | Nautilus Biotechnology, Inc. | 118.79M | 3.16% | 993,236 | 190.00K |
| 365 | AARD | Aardvark Therapeutics, Inc. | 114.68M | -2.60% | 144,241 | - |
| 366 | TENX | Tenax Therapeutics, Inc. | 113.99M | 2.58% | 6,943,792 | - |
| 367 | PMN | ProMIS Neurosciences, Inc. | 111.38M | -1.43% | 36,768 | - |
| 368 | GNLX | Genelux Corporation | 111.13M | 1.64% | 337,001 | 8.00K |
| 369 | GUTS | Fractyl Health, Inc. | 110.46M | -0.38% | 807,599 | 3.00K |
| 370 | COYA | Coya Therapeutics, Inc. | 108.84M | -2.52% | 81,965 | 8.02M |
| 371 | PYPD | PolyPid Ltd. | 108.06M | -1.30% | 82,254 | - |
| 372 | SEER | Seer, Inc. | 107.70M | -0.26% | 152,438 | 14.22M |
| 373 | ATRA | Atara Biotherapeutics, Inc. | 106.00M | 8.20% | 100,149 | 6.19M |
| 374 | ACET | Adicet Bio, Inc. | 104.41M | 1.15% | 73,252 | - |
| 375 | ONCY | Oncolytics Biotech Inc. | 104.01M | -3.26% | 1,112,872 | - |
| 376 | PMVP | PMV Pharmaceuticals, Inc. | 101.57M | 4.26% | 1,069,972 | - |
| 377 | NTHI | NeOnc Technologies Holdings, Inc. | 101.42M | -18.89% | 398,295 | 39.99K |
| 378 | PLYX | Polaryx Therapeutics, Inc. | 101.19M | 1.50% | 12,987 | - |
| 379 | ANIX | Anixa Biosciences, Inc. | 99.69M | -4.56% | 367,005 | - |
| 380 | RNXT | RenovoRx, Inc. | 99.28M | -7.95% | 1,107,114 | 1.98M |
| 381 | CGTX | Cognition Therapeutics, Inc. | 96.04M | -1.94% | 240,816 | - |
| 382 | PTHS | Pelthos Therapeutics Inc. | 92.73M | -0.53% | 39,167 | 43.30M |
| 383 | ALDX | Aldeyra Therapeutics, Inc. | 92.30M | 3.38% | 602,958 | - |
| 384 | FBIO | Fortress Biotech, Inc. | 90.55M | -0.18% | 234,727 | 68.47M |
| 385 | ACRV | Acrivon Therapeutics, Inc. | 90.42M | -0.94% | 110,379 | - |
| 386 | ICCC | ImmuCell Corporation | 90.10M | 0.20% | 6,841 | 30.68M |
| 387 | VRCA | Verrica Pharmaceuticals Inc. | 90.02M | -1.13% | 106,999 | 30.32M |
| 388 | RLYB | Rallybio Corporation | 89.32M | -0.62% | 5,823 | 646.00K |
| 389 | KLRS | Kalaris Therapeutics, Inc. | 87.48M | -5.77% | 94,993 | - |
| 390 | GOSS | Gossamer Bio, Inc. | 86.97M | 1.48% | 6,432,938 | 53.29M |
| 391 | CRDF | Cardiff Oncology, Inc. | 85.96M | 1.38% | 682,814 | 508.00K |
| 392 | MNOV | MediciNova, Inc. | 85.64M | 6.75% | 119,210 | 920.48K |
| 393 | OSTX | OS Therapies Incorporated | 84.87M | -2.13% | 1,639,078 | - |
| 394 | IBIO | iBio, Inc. | 83.92M | -0.38% | 173,396 | 100.00K |
| 395 | TELO | Telomir Pharmaceuticals, Inc. | 81.84M | 2.59% | 68,872 | - |
| 396 | YARW | Yarrow Bioscience, Inc. | 81.48M | -3.67% | 36,277 | - |
| 397 | MAIA | MAIA Biotechnology, Inc. | 80.90M | 0.76% | 195,683 | - |
| 398 | GANX | Gain Therapeutics, Inc. | 80.30M | 2.22% | 282,301 | - |
| 399 | ATHE | Alterity Therapeutics Limited | 76.53M | 0.22% | 15,558 | 2.50M |
| 400 | CING | Cingulate Inc. | 76.34M | 2.94% | 72,543 | - |
| 401 | OKYO | OKYO Pharma Limited | 76.10M | -7.64% | 271,221 | - |
| 402 | LONA | LeonaBio, Inc. | 74.81M | 5.03% | 245,891 | - |
| 403 | RNTX | Rein Therapeutics Inc. | 73.76M | -3.84% | 749,638 | - |
| 404 | NRXS | NeurAxis, Inc. | 73.59M | -1.68% | 50,946 | 5.32M |
| 405 | NTRB | Nutriband Inc. | 72.99M | 0.59% | 100,576 | 1.62M |
| 406 | DWTX | Dogwood Therapeutics, Inc. | 72.40M | -6.99% | 63,776 | - |
| 407 | BSEM | BioStem Technologies, Inc. | 71.40M | 7.82% | 381,722 | 34.59M |
| 408 | PLRX | Pliant Therapeutics, Inc. | 71.21M | -0.86% | 573,397 | - |
| 409 | INMB | INmune Bio Inc. | 69.94M | 3.28% | 484,230 | 50.00K |
| 410 | SPRO | Spero Therapeutics, Inc. | 69.59M | -1.24% | 298,203 | 47.00M |
| 411 | CSBR | Champions Oncology, Inc. | 69.47M | -4.21% | 15,131 | 59.43M |
| 412 | XBIT | XBiotech Inc. | 66.46M | -0.91% | 41,854 | - |
| 413 | EDSA | Edesa Biotech, Inc. | 64.92M | 1.59% | 15,517 | - |
| 414 | HRTX | Heron Therapeutics, Inc. | 64.61M | -1.05% | 946,700 | 151.18M |
| 415 | BOLD | Boundless Bio, Inc. | 64.60M | -1.05% | 164,508 | - |
| 416 | ALPS | Alps Group Inc | 64.06M | 1.32% | 24,223 | 3.74M |
| 417 | SER | Serina Therapeutics, Inc. | 63.25M | -8.79% | 34,151 | 130.00K |
| 418 | ELTX | Elicio Therapeutics, Inc. | 62.03M | -2.07% | 274,979 | - |
| 419 | ELOX | Eloxx Pharmaceuticals, Inc. | 61.35M | 1.33% | 25,855 | - |
| 420 | HYFT | MindWalk Holdings Corp. | 60.61M | -2.27% | 146,313 | 11.43M |
| 421 | EXOZ | eXoZymes, Inc. | 60.33M | -5.11% | 15,349 | -700.00 |
| 422 | XLO | Xilio Therapeutics, Inc. | 59.12M | -0.17% | 7,309 | 64.09M |
| 423 | IMA | ImageneBio, Inc. | 58.91M | 7.01% | 24,268 | 800.00K |
| 424 | INKT | MiNK Therapeutics, Inc. | 58.79M | -1.03% | 10,388 | - |
| 425 | MCRB | Seres Therapeutics, Inc. | 55.87M | -1.75% | 30,010 | 1.88M |
| 426 | ANVS | Annovis Bio, Inc. | 55.60M | -6.12% | 1,858,367 | - |
| 427 | HYPD | Hyperion DeFi, Inc. | 55.01M | 7.27% | 1,426,165 | 1.40M |
| 428 | IBO | Impact BioMedical Inc. | 54.02M | -7.22% | 134,449 | 35.00K |
| 429 | APLM | Apollomics, Inc. | 52.95M | -12.31% | 65,250 | 8.84M |
| 430 | TIL | Instil Bio, Inc. | 52.02M | 1.19% | 5,714 | - |
| 431 | IMMP | Immutep Limited | 50.00M | -2.16% | 241,767 | 13.79M |
| 432 | ATYR | aTyr Pharma, Inc. | 47.63M | -2.35% | 586,208 | 190.00K |
| 433 | HOWL | Werewolf Therapeutics, Inc. | 47.57M | 1.29% | 529,577 | 21.00M |
| 434 | TVGN | Tevogen Inc. | 46.79M | -2.11% | 2,487 | - |
| 435 | CELU | Celularity Inc. | 44.43M | -8.63% | 235,691 | 26.55M |
| 436 | GRCE | Grace Therapeutics, Inc. | 44.39M | 0.48% | 151,386 | - |
| 437 | VERU | Veru Inc. | 44.08M | -2.08% | 1,287,683 | 16.89M |
| 438 | MGX | Metagenomi Therapeutics, Inc. | 44.01M | -0.43% | 270,463 | 13.56M |
| 439 | MREO | Mereo BioPharma Group plc | 40.24M | 0.80% | 727,993 | 500.00K |
| 440 | KPTI | Karyopharm Therapeutics Inc. | 39.58M | -2.51% | 902,281 | 146.62M |
| 441 | FLNA | Filana Therapeutics, Inc. | 38.54M | -2.72% | 489,487 | - |
| 442 | LITS | Lite Strategy, Inc. | 38.45M | -0.88% | 241,453 | - |
| 443 | ATNM | Actinium Pharmaceuticals, Inc. | 38.36M | 18.45% | 545,239 | 35.09M |
| 444 | CRVO | CervoMed Inc. | 38.25M | -1.17% | 369,913 | 331.30K |
| 445 | NXTC | NextCure, Inc. | 38.02M | 6.23% | 67,923 | - |
| 446 | ALGS | Aligos Therapeutics, Inc. | 36.87M | -4.91% | 61,606 | 31.52M |
| 447 | CNTX | Context Therapeutics Inc. | 33.94M | 2.13% | 1,031,379 | - |
| 448 | KYNB | Kyntra Bio, Inc. | 33.45M | -3.39% | 10,269 | 4.62M |
| 449 | RNAZ | TransCode Therapeutics, Inc. | 32.68M | -6.31% | 35,010 | - |
| 450 | ACTU | Actuate Therapeutics, Inc. | 32.42M | -8.78% | 198,036 | - |
| 451 | BCTX | BriaCell Therapeutics Corp. | 31.00M | -0.84% | 137,425 | - |
| 452 | BRNS | Barinthus Biotherapeutics plc | 30.64M | -1.19% | 360,763 | 14.97M |
| 453 | QNCX | Quince Therapeutics, Inc. | 30.26M | -5.01% | 10,871 | - |
| 454 | IGC | IGC Pharma, Inc. | 30.19M | -2.01% | 542,426 | 1.11M |
| 455 | CVM | CEL-SCI Corporation | 29.37M | 2.45% | 266,188 | - |
| 456 | RADX | Radiopharm Theranostics Limited | 28.18M | 1.92% | 20,307 | 9.34M |
| 457 | ABVC | ABVC BioPharma, Inc. | 27.74M | 11.45% | 149,180 | 797.92K |
| 458 | ESLA | Estrella Immunopharma, Inc. | 27.29M | -2.92% | 52,152 | - |
| 459 | EVAX | Evaxion A/S | 27.11M | 4.17% | 59,626 | 7.49M |
| 460 | TVRD | Tvardi Therapeutics, Inc. | 25.88M | 1.57% | 155,221 | - |
| 461 | QNTM | Quantum BioPharma Ltd. | 25.80M | -1.54% | 126,215 | - |
| 462 | BYSI | BeyondSpring Inc. | 25.49M | 0.31% | 28,843 | 1.88M |
| 463 | ATOS | Atossa Therapeutics, Inc. | 25.45M | 1.19% | 34,239 | - |
| 464 | NNVC | NanoViricides, Inc. | 25.40M | -0.45% | 215,316 | - |
| 465 | LTRN | Lantern Pharma Inc. | 23.65M | -2.89% | 236,933 | - |
| 466 | TCRX | TScan Therapeutics, Inc. | 23.42M | -11.72% | 1,507,745 | 7.11M |
| 467 | GNTA | Genenta Science S.p.A. | 23.42M | 3.39% | 34,678 | - |
| 468 | JSPR | Jasper Therapeutics, Inc. | 23.30M | -1.20% | 178,428 | - |
| 469 | GRDX | GridAI Technologies Corp. | 22.87M | -0.62% | 56,069 | - |
| 470 | COCP | Cocrystal Pharma, Inc. | 22.83M | 4.87% | 58,874 | 330.00K |
| 471 | CLRB | Cellectar Biosciences, Inc. | 22.69M | 1.27% | 24,249 | - |
| 472 | AKTX | Akari Therapeutics, Plc | 22.16M | -0.78% | 122,711 | - |
| 473 | PLRZ | Polyrizon Ltd. | 21.23M | 0.89% | 163,101 | - |
| 474 | LGVN | Longeveron Inc. | 21.01M | -3.23% | 47,093 | 1.19M |
| 475 | MRKR | Marker Therapeutics, Inc. | 20.68M | 5.13% | 189,050 | 3.55M |
| 476 | PTN | Palatin Technologies, Inc. | 20.68M | -1.34% | 135,217 | 12.88M |
| 477 | CNSY | Cerenome, Inc. | 20.53M | -1.81% | 43,212 | 4.20M |
| 478 | NEUP | Neuphoria Therapeutics Inc. | 20.16M | -1.06% | 22,075 | -13.27K |
| 479 | ALLR | Allarity Therapeutics, Inc. | 20.05M | -11.27% | 224,130 | 345.00K |
| 480 | LPCN | Lipocine Inc. | 19.79M | -2.04% | 19,579 | 1.57M |
| 481 | KTTA | Pasithea Therapeutics Corp. | 19.72M | 1.76% | 262,447 | - |
| 482 | CMMB | Chemomab Therapeutics Ltd. | 19.64M | - | 91,986 | - |
| 483 | ENLV | Enlivex Ltd. | 19.58M | 1.82% | 185,290 | - |
| 484 | DYAI | Dyadic International, Inc. | 18.81M | -0.77% | 144,659 | 3.80M |
| 485 | NIKI | Niki BioSolutions, Inc. | 18.37M | 0.81% | 114,497 | - |
| 486 | NCEL | NewcelX Ltd. | 18.25M | -5.67% | 3,923 | - |
| 487 | PBM | Psyence Biomedical Ltd. | 18.08M | 4.41% | 53,780 | - |
| 488 | PDSB | PDS Biotechnology Corporation | 17.48M | 41.95% | 475,472,232 | - |
| 489 | ADIL | Adial Pharmaceuticals, Inc. | 17.04M | -8.85% | 66,993 | - |
| 490 | BCDA | BioCardia, Inc. | 16.96M | 3.70% | 123,965 | 3.00K |
| 491 | LSTA | Lisata Therapeutics, Inc. | 16.94M | 13.94% | 237,000 | 100.00K |
| 492 | NRSN | NeuroSense Therapeutics Ltd. | 16.60M | -12.08% | 1,003,900 | - |
| 493 | CTXR | Citius Pharmaceuticals, Inc. | 16.49M | 2.19% | 295,775 | 7.11M |
| 494 | CYCN | Cyclerion Therapeutics, Inc. | 16.13M | -17.65% | 422,953 | 1.90M |
| 495 | PASG | Passage Bio, Inc. | 15.74M | 5.16% | 12,058 | - |
| 496 | LEXX | Lexaria Bioscience Corp. | 15.72M | -32.79% | 116,666 | 194.00K |
| 497 | TPST | Tempest Therapeutics, Inc. | 15.70M | -4.62% | 192,596 | - |
| 498 | BIVI | BioVie Inc. | 15.61M | 3.50% | 306,603 | - |
| 499 | MBRX | Moleculin Biotech, Inc. | 14.87M | 7.54% | 726,586 | - |
| 500 | HIND | Vyome Holdings, Inc. | 14.81M | -4.95% | 18,163 | 129.73K |